Use of mycrobacterial vaccines in CD4
View Patent ↗Methods of treating a mammal that is deficient in CD4 + and/or CD8 + lymphocytes are provided. The methods comprise inoculating the mammal with an attenuated mycobacterium in the M. tuberculosis complex. In these methods, the mycobacterium comprises two deletions, wherein a virulent mycobacterium in the M. tuberculosis complex having either deletion exhibits attenuated virulence. Use of these mycobacteria for the manufacture of a medicament for the treatment of mammals deficient in CD4 + and/or CD8 + lymphocytes is also provided.
1. A method for inoculating an immunocompromised mammal against Mycobacterium tuberculosis , wherein the mammal does not have severe combined immune deficiency but is deficient in CD4 + lymphocytes or in CD8 + lymphocytes, the method comprising administering to the immunocompromised mammal an amount of an attenuated M. tuberculosis or M. bovis mycobacterium effective to confer protection against Mycobacterium tuberculosis in the mammal, wherein the attenuated mycobacterium has (i) a deletion of RD1 and is auxotrophic for pantothenate, or (ii) is auxotrophic for both lysine and pantothenate.
2. The method of claim 1 , wherein the attenuated mycobacterium is an M. tuberculosis.
3. The method of claim 1 , wherein the attenuated mycobacterium is an M. bovis.
4. The method of claim 1 , wherein the mammal is a human.
5. The method of claim 1 , wherein the RD1 deletion is a ΔpanCD deletion.
6. The method of claim 1 , wherein the mammal is deficient in CD8 + lymphocytes.
7. The method of claim 1 , wherein the mammal is deficient in CD4 + lymphocytes.
8. The method of claim 1 , wherein the attenuated mycobacterium has a deletion of RD1 and is auxotrophic for pantothenate.
9. The method of claim 1 , wherein the attenuated mycobacterium is auxotrophic for both lysine and pantothenate.